ActX

About:

ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.

Top Investors: Keiretsu Capital, Keiretsu Forum, Alliance of Angels, Puget Sound Venture Club

Description:

ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice. The company provides actionable clinical information based on their patient's genetics. It was founded in 2013 and headquartered in Seattle, Washington.

Total Funding Amount:

$9.91M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)actx.com

Founders:

Andrew Ury, Mark Poznansky

Number of Employees:

11-50

Last Funding Date:

2022-12-31

IPO Status:

Private

Industries: